SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant (Q99561921)
Jump to navigation
Jump to search
scientific article published on 04 September 2020
Language | Label | Description | Also known as |
---|---|---|---|
English | SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant |
scientific article published on 04 September 2020 |
Statements
SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant (English)
Yoriyuki Konno
Izumi Kimura
Keiya Uriu
Masaya Fukushi
Takashi Irie
Yoshio Koyanagi
Daniel Sauter
Robert J Gifford
USFQ-COVID19 Consortium
So Nakagawa
4 September 2020
32
0 references
12
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference